Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5809_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
24 Мб
Скачать
2 Basics ofThree-Dimensional Ultrasound andApplications inReproductive Medicine
37
Fig. 2.11 (continued)

Conclusions

Three-dimensional US opens up new clinical applications and facilitates many of the proce­dures originally performed with 2D US.Three­dimensional US offers some features not available with 2D US; this includes measure­ments in 3D space– including volume calcula­tions– with high accuracy, even for non-regular shaped structures, display of an arbitrary section, and displaying a 3D image. Currently, in most fertility clinics, 3D US is not a diagnostic arma­mentarium, although it has become an indispens­able tool in many specialty elds, such as prenatal diagnosis, neurology, or cardiology. However, we are witnessing a still growing interest in this stunning technique being implemented in many research settings within the scope of gynecology and reproductive medicine. Nowadays, within the scope of fertility therapy, 3D US has already
become established as the preferred method for diagnosing uterine malformations. It may also play an increasingly important role in the near future when it comes to the accurate diagnosis of PCOS, in the assessment of ovarian reserve, and in estimating the risk of OHSS.Thus, 3D US will become one of the decision-making factors in choosing the optimal stimulation protocol and in monitoring follicular development, an area where 3D applications have the potential for optimizing the IVF process and setting benchmarks for stan­dardization, i.e., in the process of COS.
When 3D US data is acquired, the information can be stored for documentation (which might be needed for future therapy planning and most important for legal reasons) or post-processing. It can be easily shared for an expert review, inter­disciplinary consultation, teaching, and/or tele­medicine. Additionally, data can be sent between IVF centers and the attending gynecologist,
38
M. Murtinger and M. Schu
which is most important for a patient-friendly therapy. Thereby, data can be transferred through a secured connection via a PACS server and vir­tual private network (VPN) tunneling, and the corresponding medical software allows seamless integration of all processes needed for an accu­rate and precise workow [81].
Meanwhile, there are various post-processing modalities available. However, a lack of stan­dardization, the time needed for post-processing, and operators who are often insufciently trained are still obstacles to a broader application of 3D US and its use in a clinical setting. This last point is of particular importance, since the application of 3D techniques denitely needs extensive train­ing and a learning curve [82]. There is a clear trend toward rapid increasing processing power, improved image quality, and more user-friendly instruments and software. However, manufac­tures should be encouraged to provide training modules and more user-friendly software for post-processing to allow a higher acceptance of 3D US techniques. Additionally, the implementa­tion and usage of portable 3D US systems might possibly accelerate the application of 3D US.Thus, there is no doubt that new innovation will offer new application areas even within ART.

References

1. Ahirwar C. 3D/4D ultrasound equipment market to
grow at a CAGR of 7.03% during the period 2017–
2021. Red Newsire Global. Available from: https://
www.rednewswire.com/global-3d-4d-ultrasound-
equipment-market-to-grow-at-a-cagr-of-7-03-during-
the-period-2017-2021/. Last Accessed on 18 May
2018.
2. Salomon LJ, Alrevic Z, Bilardo CM, Chalouhi GE,
Ghi T, Kagan KO, etal. SUOG practice guidelines:
performance of rst-trimester fetal ultrasound scan.
Ultrasound Obstet Gynecol. 2013;41:102–13.
3. Curie P, Curie J. Dévelopment, par pression, de
l’électricité polaire dans les cristaux hémièdres à faces
inclinées. C R Hébd Séances Acad Sci. 1880;91:294–5.
4. Szabo TL, Lewin PA. Ultrasound transducer selec-
tion in clinical imaging practice. J Ultrasound Med.
2013;32:573–82.
5. Martin K, Ramnarine K. Physics. In: Hoskins PR,
Martin K, Thrush A, editors. Diagnostic ultrasound:
physics and equipment. 2nd ed. Cambridge, UK:
Cambridge University Press; 2010.
6. Miller DL.Safety assurance in obstetrical ultrasound. Semin Ultrasound CT MR. 2008;29:156–64. Review.
7. Ultrasonic Systems. Radiology key. Available from:
https://radiologykey.com/ultrasonic-systems/. Last
Accessed on 30 May 2018.
8. Hua S, Yuchi M, Ding M. Computer Simulation for medical ultrasound c-mode imaging based on 2d array. Adv Mat Res. 2012;532(533):719–23. Available from: http://citeseerx.ist.psu.edu/viewdoc/
download?doi=10.1.1.911.7989&rep=rep1&type= pdf. Last Accessed on 18 May 2018.
9. Merz E. 3D ultrasound in prenatal diagnosis. Curr Obstet Gynecol. 1999;9:93–100.
10. Doppler C.Ueber das farbige Licht der Doppelsterne und einiger anderer Gestirne des Himmels. Verlag der königl. böhm. Gesellschaft der Wissenschaften. 1903. Bd. 2, S. 465–482). Available from: http://digital.bib-
bvb.de/view/bvbmets/viewer.0.6.2.jsp?folder_id=0& dvs=1528188779301~287&pid=5210835&locale=de &usePid1=true&usePid2=true#. Last Accessed on 30
May 2018.
11. Yamasato K, Zalud I. Three dimensional power Doppler of the placenta and its clinical applications. J Perinat Med. 2017;45:693–700. Review.
12. Gonçalves LF, Espinoza J, Kusanovic JP, Lee W, Nien JK, Santolaya-Forgas J, etal. Applications of 2-dimen­sional matrix array for 3- and 4- dimensional examina­tion of the fetus: a pictorial essay. J Ultrasound Med. 2006;25:745–55.
13. Campbell S. A short history of sonography in obstetrics and gynaecology. Facts Views Vis Obgyn. 2013;5:213–29.
14. Prager RW, Ijaz UZ, Gee AH, Treece GM. Three­dimensional ultrasound imaging. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine. 2010;224:193–223.
15. Fenster A, Downey DB. 3-D ultrasound imaging: a review. IEEE Eng Med Biol Mag. 1996;15:41–51.
16. Zhang H, Banovac F, White A, Cleary K.Freehand 3D ultrasound calibration using an electromagneti­cally tracked needle. Available from: http://spie.org/
Publications/Proceedings/Paper/10.1117/12.654906.
Last Accessed on 20 May 2018.
17. Fenster A, Downey DB, Cardinal HN. Three­dimensional ultrasound imaging. Phys Med Biol. 2001;46:R67–99. Review.
18. Baba K. Development of 3D ultrasound. Donald Sch J Ultrasound Obstet Gynecol. 2010;4:205–15. Available from: https://www.dsjuog.com/doi/
pdf/10.5005/jpjournals-10009-1144. Last Accessed
on 02 May 2019.
19. De Jong-Pleij EA, Ribbert LS, Tromp E, Bilardo CM. Three-dimensional multiplanar ultrasound is a valuable tool in the study of the fetal prole in the second trimester of pregnancy. Ultrasound Obstet Gynecol. 2010;35:195–200.
20. Wong L, White N, Ramkrishna J, Araujo Júnior E, Meagher S, Costa Fda S.Three-dimensional imaging of the uterus: the value of the coronal plane. World J Radiol. 2015;7:484–93. Review.
2 Basics ofThree-Dimensional Ultrasound andApplications inReproductive Medicine
39
21. Dietz HP, Shek KL. Tomographic ultrasound imag­ing of the pelvic oor: which levels matter most? Ultrasound Obstet Gynecol. 2009;33:698–703.
22. Ruano R. Recent advances in sonographic imaging of fetal thoracic structures. Expert Rev Med Devices. 2005;2:217–22. Review.
23. Jouannic JM, Rosenblatt J, Demaria F, Jacobs R, Aubry MC, Benia JL. Contribution of three­dimensional volume contrast imaging to the sono­graphic assessment of the fetal uterus. Ultrasound Obstet Gynecol. 2005;26:567–70.
24. Principles of 3D Ultrasound. Radiology Key. Available from: https://radiologykey.com/principles-
of-3d-ultrasound/. Last Accessed on 20 May 2018.
25. Alcázar JL. The use of three-dimensional ultrasound in gynecological patients. Donald Sch J Ultrasound Obstet Gynecol. 2008;2:10–6. Available from:
https://pdfs.semanticscholar.org/8e47/ f112875922a165e972af6f7d80df477046bb. pdf?_ga=2.166936311.817103330.1556788335-
777804567.1540477073. Last Accessed on 02 May
2019.
26. Benacerraf BR.Inversion mode display of 3D sonog­raphy: applications in obstetric and gynecologic imaging. AJR Am J Roentgenol. 2006;187:965–71. Review.
27. Timor-Tritsch IE, Monteagudo A, Tsymbal T. Three­dimensional ultrasound inversion rendering tech­nique facilitates the diagnosis of hydrosalpinx. J Clin Ultrasound. 2010;38:372–6.
28. Weber G, Merz E, Bahlmann F, Macchiella D. Ultrasound assessment of ovarian tumors–com­parison between transvaginal 3D technique and con­ventional 2-dimensional vaginal ultrasonography. Ultraschall Med. 1997;18:26–30.
29. Campbell S. The potential diagnostic capabilities of three-dimensional surface rendering. Ultrasound Obstet Gynecol. 1999;14:148.
30. Turan S, Turan O, Baschat AA. Three- and four­dimensional fetal echocardiography. Fetal Diagn Ther. 2009;25:361–72. Review.
31. Adriaanse BM, Tromp CH, Simpson JM, Van Mieghem T, Kist WJ, Kuik DJ, etal. Interobserver agreement in detailed prenatal diagnosis of con­genital heart disease by telemedicine using four­dimensional ultrasound with spatiotemporal image correlation. Ultrasound Obstet Gynecol. 2012;39:203–9.
32. Yeo L, Romero R, Jodicke C, Oggè G, Lee W, Kusanovic JP, et al. Four-chamber view and ‘swing technique’ (FAST) echo: a novel and sim­ple algorithm to visualize standard fetal echocar­diographic planes. Ultrasound Obstet Gynecol. 2011;37:423–31.
33. Merz E, Miric-Tesanic D, Welter C. Value of the electronic scalpel (cut mode) in the evalua­tion of the fetal face. Ultrasound Obstet Gynecol. 2000;16:564–8.
34. Powers J, Kremkau F. Medical ultrasound systems. Interface Focus. 2011;1:477–89.
35. Udupa JK. Three-dimensional visualization and analysis methodologies: a current perspective. Radiographics. 1999;19:783–806. Review.
36. Ong CL. The current status of three-dimensional ultrasonography in gynaecology. Ultrasonography. 2016;35:13–24. Review.
37. Zalud I, Rocha F. Artifacts, pitfalls and normal variants. Donald Sch J Ultrasound. 2012;6:1–8. Available from: https://www.dsjuog.com/doi/
pdf/10.5005/jp-journals-10009-1221. Last Accessed
on 02 May 2019.
38. Baba K, Satoh K.Development of a system for ultra­sonic fetal three-dimensional reconstruction. Acta Obstet Gynaecol Jpn. 1986;38:1385.
39. Baba K, Satch K, Sakamoto S, Oka T, Shiego I. Development of an ultrasonic system for three­dimensional reconstruction of the fetus. J Perinat Med. 1989;17:19–24.
40. Von Ramm OT, Smith SW.Three-dimensional imag­ing system. 1987. United States Patent 4694434. Available from: http://www.freepatentsonline.
com/4694434.html. Last accessed on 20 May 2018.
41. From Wired Frames to 3D. A short History of Kretztechnik AG, Zipf, Austria. Available from:
http://www.ob-ultrasound.net/kretztechnik.html. Last
accessed on 23 May 2018.
42. Lees W.Ultrasound imaging in three and four dimen­sions. Semin Ultrasound CT MR. 2001;22:85–105. Review.
43. Sohn C, Stolz W, Nuber B, Hesse A, Hornung B. Three-dimensional ultrasonic diagnosis in gyne­cology and obstetrics. Geburtshilfe Frauenheilkd. 1991;51:335–40.
44. Steiner H, Staudach A, Spitzer D, Graf AH, Wienerroither H. Does 3D sonography present new perspectives for gynecology and obstetrics? Geburtshilfe Frauenheilkd. 1993;53:779–82.
45. Steiner H, Spitzer D, Weiss-Wichert PH, Graf AH, Staudach A. Three-dimensional ultrasound in pre­natal diagnosis of skeletal dysplasia. Prenat Diagn. 1995;15:373–7.
46. Bonilla-Musoles F, Raga F, Osborne NG, Blanes J. Use of three-dimensional ultrasonography for the study of normal and pathologic morphology of the human embryo and fetus: preliminary report. J Ultrasound Med. 1995;14:757–65.
47. Merz E, Pashaj S. Current role of 3D/4D sonogra­phy in obstetrics and gynecology. Donald School J Ultrasound Obstet Gynecol. 2013;7:400–8.
48. Woo J. A short History of the development of Ultrasound in Obstetrics and Gynecology. Available from: http://www.ob-ultrasound.net/isuog3dfocus.
html. Last accessed on 23 May 2018.
49. Merton D.Diagnostic medical ultrasound technology: a brief historical review. J Diagn Med Sonography. 1997;13:10S–23S.
50. Brandl H, Gritzky A, Haizinger M. 3D ultrasound: a dedicated system. Eur Radiol. 1999;9:331–3. Review.
51. Grimbizis GF, Di Spiezio Sardo A, Saravelos SH, Gordts S, Exacoustos C, et al. The Thessaloniki
40
M. Murtinger and M. Schu
ESHRE/ESGE consensus on diagnosis of female genital anomalies. Hum Reprod. 2016;31:2–7.
52. Deb S, Campbell BK, Clewes JS, Raine-Fenning NJ.Quantitative analysis of antral follicle number and size: a comparison of two-dimensional and automated three-dimensional ultrasound techniques. Ultrasound Obstet Gynecol. 2010;35:354–60.
53. Coelho Neto MA, Ludwin A, Borrell A, Benacerraf B, Dewailly D, da Silva Costa F, etal. Counting ovar­ian antral follicles by ultrasound: a practical guide. Ultrasound Obstet Gynecol. 2018;51:10–20.
54. Nylander M, Frøssing S, Bjerre AH, Chabanova E, Clausen HV, Faber J, et al. Ovarian morphology in polycystic ovary syndrome: estimates from 2D and 3D ultrasound and magnetic resonance imaging and their correlation to anti-Müllerian hormone. Acta Radiol. 2017;58:997–1004.
55. Lam PM, Raine-Fenning N. The role of three­dimensional ultrasonography in polycystic ovary syn­drome. Hum Reprod. 2006;21:2209–15.
56. Rotterdam ESHRE/ASRM-Sponsored PCOS con­sensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7.
57. Lam PM, Johnson IR, Raine-Fenning NJ. Three­dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. Hum Reprod. 2007;22:3116–23.
58. Alcázar JL, Jurado M. Three-dimensional ultra­sound for assessing women with gynecologi­cal cancer: a systematic review. Gynecol Oncol. 2011;120:340–6.
59. Stachowiak G, Zając A, Pertynska-Marczewska M, Stetkiewicz T. 2D/3D ultrasonography for endome­trial evaluation in a cohort of 118 postmenopausal women with abnormal uterine bleedings. Ginekol Pol. 2016;87:787–92.
60. Chan YY, Jayaprakasan K, Tan A, Thornton JG, Coomarasamy A, Raine-Fenning NJ. Reproductive outcomes in women with congenital uterine anoma­lies: a systematic review. Ultrasound Obstet Gynecol. 2011;38:371–82. Review.
61. Saravelos SH, Cocksedge KA, Li TC.Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. Hum Reprod Update. 2008;14:415–29.
62. Hassan MA, Lavery SA, Trew GH.Congenital uter­ine anomalies and their impact on fertility. Womens Health (Lond). 2010;6:443–61. Review.
63. Turkgeldi E, Urman B, Ata B. Role of three­dimensional ultrasound in gynecology. J Obstet Gynaecol India. 2015;65:146–54. Review.
64. Bonilla-Musoles F, Martin N, Pepa Esquembre M, Caballero O. Uterine malformations: diagnosis with 3D/4D ultrasound. Donald School J Ultrasound Obstet Gynecol. 2015;9:123–48.
65. ESHRE Early Pregnancy Guideline Development Group. Recurrent pregnancy loss. Guideline of the European Society of Human Reproduction
and Embryology, 2017. Available from: https://
www.eshre.eu/Guidelines-and-Legal/Guidelines/ Recurrent-pregnancy-loss.aspx. Last Accessed on 02
May 2019.
66. Kim MJ, Lee Y, Lee C, Chun S, Kim A, Kim HY, etal. Accuracy of three dimensional ultrasound and treat­ment outcomes of intrauterine adhesion in infertile women. Taiwan J Obstet Gynecol. 2015;54:737–41.
67. Luciano DE, Exacoustos C, Albrecht L, LaMonica R, Proffer A, Zupi E, etal. Three-dimensional ultra­sound in diagnosis of adenomyosis: histologic corre­lation with ultrasound targeted biopsies of the uterus. J Minim Invasive Gynecol. 2013;20:803–10.
68. Exacoustos C, Brienza L, Di Giovanni A, Szabolcs B, Romanini ME, Zupi E, etal. Adenomyosis: three­dimensional sonographic ndings of the junctional zone and correlation with histology. Ultrasound Obstet Gynecol. 2011;37:471–9.
69. Struble J, Reid S, Bedaiwy MA.Adenomyosis: a clin­ical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016;23:164–85.
70. Yaman C, Sommergruber M, Ebner T, Pölz W, Moser M, Tews G. Reproducibility of transvaginal three­dimensional endometrial volume measurements during ovarian stimulation. Hum Reprod. 1999;14:2604–8.
71. Vanderzwalmen P, Zech NH, Ectors F, Stecher A, Lejeune B, Vanderzwalmen S, etal. Blastocyst trans­fer after aseptic vitrication of zygotes: an approach to overcome an impaired uterine environment. Reprod Biomed Online. 2012;25:591–9.
72. Quigley MM, Sokoloski JE, Richards SI. Timing human chorionic gonadotropin administration by days of estradiol rise. Fertil Steril. 1985;44:791–5.
73. Wirleitner B, Okhowat J, Vištejnová L, Králíčková M, Karlíková M, Vanderzwalmen P, et al. Relationship between follicular volume and oocyte competence, blastocyst development and live-birth rate: optimal follicle size for oocyte retrieval. Ultrasound Obstet Gynecol. 2018;51:118–25.
74. Kyei-Mensah A, Zaidi J, Pittrof R, Shaker A, Campbell S, Tan SL.Transvaginal three-dimensional ultrasound: accuracy of follicular volume measure­ments. Fertil Steril. 1996;65:371–6.
75. Hernández J, Rodríguez-Fuentes A, Puopolo M, Palumbo A. Follicular volume predicts oocyte maturity: a prospective cohort study using three­dimensional ultrasound and SonoAVC. Reprod Sci. 2016;23:1639–43.
76. Singh N, Usha BR, Malik N, Malhotra N, Pant S, Vanamail P. Three-dimensional sonography-based automated volume calculation (SonoAVC) versus two-dimensional manual follicular tracking in invitro fertilization. Int J Gynaecol Obstet. 2015;13:166–9.
77. Vandekerckhove F, Bracke V, De Sutter P.The value of automated follicle volume measurements in IVF/ ICSI.Front Surg. 2014;1:18. Review.
78. Murtinger M, Aburumieh A, Rubner P, Eichel V, Zech MH, Zech NH. Improved monitoring of ovar­ian stimulation using 3D transvaginal ultrasound plus
2 Basics ofThree-Dimensional Ultrasound andApplications inReproductive Medicine
41
automated volume count. Reprod Biomed Online. 2009;19:695–9.
79. Revelli A, Martiny G, Delle Piane L, Benedetto C, Rinaudo P, Tur-Kaspa I. A critical review of bi­dimensional and three-dimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome? Reprod Biol Endocrinol. 2014;12:107.
80. Martins WP, Vieira CV, Teixeira DM, Barbosa MA, Dassunção LA, Nastri CO.Ultrasound for monitoring controlled ovarian stimulation: a systematic review
and meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol. 2014;43:25–33. Review.
81. Murtinger M, Zech MH, Spitzer D, Zech NH. Outpatient follicle monitoring: a plea for stan­dardization in ultrasound based follicle monitoring and data transfer. J Reprod Infertil. 2014;15:105–8.
82. Rodriguez A, Guillén JJ, López MJ, Vassena R, Coll O, Vernaeve V. Learning curves in 3-dimen­sional sonographic follicle monitoring during con­trolled ovarian stimulation. J Ultrasound Med. 2014;33:649–55.
Two-Dimensional andThree­Dimensional Doppler inReproductive Medicine
ErnestHungYuNg
3

Introduction

In vitro fertilization-embryo transfer (IVF-ET) is an effective treatment for various causes of infer­tility and involves the development of multiple follicles, oocyte retrieval and embryo transfer after fertilization. Multiple embryos are still being replaced in order to compensate for their low implantation potential, which have remained steady at 30% for a long time. The development of multiple follicles in response to gonadotrophin stimulation is considered as the key factor lead­ing to successful outcome. Successful implanta­tion is dependent on interaction between a good quality embryo and a receptive endometrium.
Ultrasound examination is essential during IVF for predicting and monitoring the ovarian response to gonadotrophin, assessing the endo­metrium, guiding the transvaginal aspiration of oocytes and transferring embryos to the uterine cavity. Angiogenesis plays a critical role in vari­ous female reproductive processes such as the development of a dominant follicle, formation of a corpus luteum, growth of endometrium and implantation [1, 2]. This chapter covers the use of two dimensional (2D) and three dimensional
E. H. Y. Ng (*) Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong, SAR, China e-mail: nghye@hku.hk
(3D), in particular the role of endometrial and subendometrial blood ow determined by Doppler ultrasound in predicting the IVF success and the role of ovarian stromal blood ow deter­mined by Doppler ultrasound in predicting ovar­ian response.

Endometrial Blood Flow

Ultrasound examination of the endometrium pro­vides a noninvasive evaluation of the endome­trium during IVF [3]. Ultrasound parameters of endometrial receptivity include endometrial thickness, endometrial pattern, endometrial vol­ume and Doppler study of uterine arteries and the endometrium. Endometrial thickness and pattern have low positive predictive value and specicity for the IVF outcome [4, 5], whereas endometrial volume measured by 3D ultrasound is not predic­tive of pregnancy [69].
Assessment of endometrial blood ow adds a physiological dimension to the anatomical ultra­sound parameters. A good blood ow towards the endometrium is usually considered as an essen­tial requirement for successful implantation. Jinno et al. [10] measured endometrial tissue blood ow in infertile women by the intrauterine laser Doppler technique between days 4 and 6 of the luteal phase of a spontaneous cycle preceding IVF. The IVF pregnancy rate was signicantly higher in women with endometrial tissue blood
© Springer Nature Switzerland AG 2019 L. A. Stadtmauer, I. Tur-Kaspa (eds.), Ultrasound Imaging in Reproductive Medicine,
https://doi.org/10.1007/978-3-030-16699-1_3
43
44
E. H. Y. Ng
ow of at least 29mL/min per 100 gm of tissue than in women with lower values (42% vs 15%, respectively, P<0.05).
Endometrial blood ow starts from the radial artery, which divides after passing through the myometrial-endometrial junction to form the basal arteries that supply the basal portion of the endometrium and the spiral arteries that continue up towards the endometrium. Endometrial blood ow can be determined by colour and power Doppler ultrasound. Power Doppler imaging is more sensitive than colour Doppler imaging at detecting low velocity ow and hence improves the visualization of small vessels [11]. In combi­nation with 3D ultrasound, power Doppler pro­vides a unique tool with which to examine the blood ow of both endometrial and subendome­trial regions.
Blood Flow ofUterine Vessels
Doppler study of uterine vessels reecting down­stream impedance to ow has been assumed to reect the blood ow towards the endometrium. It is usually expressed as the pulsatility index (PI) and the resistance index (RI) (Fig.3.1). PI is cal­culated as the peak systolic velocity (PSV) minus end-diastolic velocity divided by the mean, whereas RI is the ratio of PSV minus end­diastolic velocity divided by PSV.
Flow velocity waveforms are obtained from the ascending main branch of the uterine artery on the right and left side of the cervix in a longi­tudinal plane before it enters the uterus. The ‘gate’ of the Doppler is positioned when the ves­sel with good colour signals is identied on the screen. The PI and RI of the uterine arteries were calculated electronically when three similar, con­secutive waveforms of good quality were obtained.
Good uterine blood ow as shown by low PI or RI is correlated with successful IVF outcomes [12, 13]. Steer etal. [12] classied PI measured on the day of ET as low, medium and high in the ranges of 0–1.99, 2.00–2.99 and 3.00, respec­tively, and reported a 35% implantation failure when PI was >3.0. Using a PI upper limit of 3.0
[12] or 3.3 [13], the uterine Doppler ow indices have a high negative predictive value and sensi­tivity (in the ranges of 88–100% and 96–100%, respectively) and a relatively higher range of positive predictive value and specicity (44–56% and 13–35%, respectively) when compared with endometrial thickness and pattern [5].
Uterine artery Doppler study may not reect the actual blood ow to the endometrium as the major compartment of the uterus is the myome­trium, and there is collateral circulation between uterine and ovarian vessels. I have shown that 2D Doppler study of uterine vessels is a poor reection of subendometrial blood ow by 3D power Doppler in both stimulated and natural cycles as endometrial and subendometrial 3D Doppler ow indices were similar among patients with averaged uterine PI <2.0, 2.0–2.99 and 3.0 [14].
Endometrial andSubendometrial Blood Flow by 2D Doppler
Endometrial and subendometrial blood ow examined by colour (Table 3.1) and power Doppler (Table3.2) were correlated with implan­tation or pregnancy rates of IVF. 2D Doppler ow indices of spiral arteries such as PI and PSV are not predictive of pregnancy [8, 15, 16], although Battaglia etal. [17] and Kupesic etal. [18] found signicantly lower spiral artery PI in pregnant cycles than non-pregnant cycles.
Yang et al. [19] used a computer software to measure the area and intensity of colour signals present in the endometrium in a longitudinal axis, i.e. intraendometrial power Doppler area (EDPA). Signicantly higher EDPA was found in pregnant cycles than non-pregnant cycles (8.8 mm
5.8 mm2, respectively). Patients with EDPA <5 mm2 had signicantly lower pregnancy rate (23.5% vs 47.5%; P = 0.021) and implantation rate (8.1% vs 20.2%; P=0.003) than those with 5mm2. Contart etal. [20] graded endometrial blood ow by the visualization of power Doppler in the quadrants in the fundal region of the trans­verse plane but could not demonstrate any pre­dictive value of such grading system.
2
vs
3 Two-Dimensional andThree-Dimensional Doppler inReproductive Medicine
a
45
b
Fig. 3.1 (a, b) Uterine blood ow measured by 2D Doppler ultrasound
46
Table 3.1 Summary of studies of endometrial blood ow by 2D colour Doppler
Study IVF cycles USS parameters Zaidi etal.
(1995) [15]
Battaglia etal. (1997) [17]
Chien etal. (2002) [21]
USS ultrasound, PI pulsatility index, PSV peak systolic velocity, OR oocyte retrieval, ET embryo transfer
Table 3.2 Summary of studies of endometrial blood ow by 2D power Doppler
Study IVF cycles USS parameter Yang etal.
(1999) [19]
Yuval etal. (1999) [16]
Contart etal. (2000) [20]
Schild etal. (2001) [26]
Maugey­Laulom etal. (2002) [22]
USS ultrasound, PI pulsatility index, PSV peak systolic velocity, OR oocyte retrieval, ET embryo transfer
96cycles using a long protocol
60cycles Uterine and spiral PI OR Uterine and spiral PI lower in pregnant
623cycles using ultrashort and ultralong protocols
95cycles using long and short protocols Endometrium 10mm 156cycles using a long protocol
185cycles using a long protocol
135cycles using a long protocol; rst cycle only
144cycles using a long protocol
Spiral PI and PSV hCG No difference in subendometrial PI and
Presence of endometrial and subendometrial ow
Presence of endometrial blood ow Uterine and spiral PI and RI ET Signicantly lower implantation and Presence of endometrial and subendometrial (<10mm) blood ow Presence of subendometrial ow 5.9
Intraendometrial power Doppler area (EDPA)
2
<5mm
PI and RI OR
Fundal region along transverse plan Grades I, II, III and IV according to visualization of power Doppler in the quadrants PI and PSV of vessels in endometrium and subendometrial area (<5mm)
Presence of endometrial and subendometrial blood ow
; 5mm
2
USS day Results
PSV between pregnant and non­pregnant cycles Absent subendometrial ow associated with no pregnancy
than non-pregnant cycles Absent subendometrial ow associated with no pregnancy
pregnancy rates in patients without endometrial /subendometrial ow
times to become pregnant than those with absent ow
USS day Results
OR Higher EDPA in pregnant cycles
Lower implantation and pregnancy rates when EDPA
2
<5mm No difference in any USS parameters between pregnant and
and
non-pregnant cycles
ET hCG Implantation and pregnancy rates
similar in all grades of endometrial vascularity
OR No difference in spiral artery PI
and PSV between pregnant and non-pregnant cycles Non-detectable spiral blood ow was not associated with a lower implantation rate
ET Absent endometrial and
subendometrial ow associated with a lower pregnancy rate
E. H. Y. Ng
The presence of endometrial and subendome­trial blood ow can be identied easily in 2D Doppler ultrasound. Absent endometrial and sub­endometrial blood ow has been shown to be associated with no pregnancy [15, 17] or a sig­nicantly lower pregnancy rate [21, 22].
Endometrial andSubendometrial Blood Flow by 3D Doppler
3D power Doppler ultrasound with the aid of the VOCAL® (virtual organ computer-aided analy­sis) imaging program for the 3D power Doppler
3 Two-Dimensional andThree-Dimensional Doppler inReproductive Medicine
47
histogram has been used to measure endometrial volume and indices of blood ow within the endometrium (Fig. 3.2). Vascularization index (VI), which measures the ratio of the number of colour voxels to the number of all the voxels, is thought to represent the presence of blood vessels (vascularity) in the endometrium, and this was expressed as a percentage (%) of the endometrial volume. Flow index (FI), the mean power Doppler signal intensity inside the endometrium, is thought to express the average intensity of ow. Vascularization ow index (VFI) is a com­bination of vascularity and ow intensity [23].
The subendometrium can be examined through the application of ‘shell-imaging’ which allows the user to generate a variable contour that parallels the originally dened surface contour. The VI, FI and VFI of the subendometrial region are obtained accordingly (Fig. 3.3). The intra­observer and interobserver reliability of endome­trial and subendometrial blood ow by 3D power Doppler have been conrmed to be high with all measurements obtaining an intra-class correla­tion of above 0.9 [24, 25].
Studies addressing the role of endometrial and subendometrial blood ow measured by 3D Doppler in IVF treatment are summarised in Table3.3. Schild etal. [26] measured the suben­dometrial blood ow after pituitary downregula­tion but prior to ovarian stimulation and showed that subendometrial VI, FI and VFI were signi­cantly lower in pregnant cycles than non- pregnant ones. Logistic regression analysis found that the subendometrial FI was the strongest predictive factor for the pregnancy outcome among other 3D Doppler ow indices.
Kupesic etal. [18] performed 3D ultrasound examination on the day of blastocyst transfer and found that subendometrial FI was signicantly higher in pregnant cycles. Subendometrial VI and VFI were similar between pregnant and non­pregnant patients. Wu etal. [27] measured suben­dometrial blood ow on the day of hCG and demonstrated that subendometrial VFI was sig­nicantly higher in the pregnant group. Subendometrial VI and FI were also similar between pregnant and non-pregnant cycles. Subendometrial VFI was superior to subendome-
trial VI, subendometrial FI and endometrial vol­ume in predicting the successful outcome in the receiver operating characteristics (ROC) curve analysis.
On the day of oocyte retrieval, Dorn etal. [28] compared the subendometrial blood ow before and after an intravenous administration of Levovist, which is a contrast agent and consists of 99.9% of D-galactose. All subendometrial 3D Doppler ow indices after the administration of the contrast agent were signicantly higher than those without the contrast agent. However, all subendometrial 3D Doppler ow indices with and without the contrast agent were comparable between pregnant and non-pregnant cycles. The results of this study suggested that the use of 3D power Doppler ultrasound under a contrast agent during IVF treatment provided no additional advantage over the conventional 3D power Doppler ultrasound examination.
Järvelä etal. [29] determined endometrial and subendometrial VI after gonadotrophin stimula­tion but before hCG administration and again the day of oocyte retrieval. There were no differences between the pregnant and non-pregnant groups in endometrial and subendometrial VI on either day examined. I have published the largest study involving 451 transfer cycles [30]. Patients in the pregnant group had signicantly lower uterine RI, endometrial VI and VFI than those in the non­pregnant group. Endometrial thickness, endome­trial volume, endometrial pattern, uterine PI, endometrial FI and subendometrial VI, FI and VFI were similar between the non-pregnant and preg­nant groups. The number of embryos replaced and endometrial VI were the only two predictive fac­tors for pregnancy in a logistic multiple regression analysis. ROC curve analysis revealed that the area under the curve was around 0.5 for all ultrasound parameters for endometrial receptivity.
Implantation and pregnancy rates were com­parable for patients with and without endometrial and subendometrial blood ow [30]. This nding is contradictory to those obtained by 2D Doppler ultrasound, which suggested that absent endome­trial and subendometrial blood ows were asso­ciated with no pregnancy [15, 17] or much reduced pregnancy rate [21, 22].